share_log

Fulcrum Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Suvretta Capital Management, LLC(8.9%),Aaron Cowen(8.9%), etc.

SEC announcement ·  Feb 13 12:10
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more